doi:10.3969/j.issn.1673-8640.2022.01.021

Abstract

CLC Number:

R446.11

Figures/Tables 3

References 9

[1]	VALDÉS L, ALVAREZ D, VALLE J M, et al. The etiology of pleural effusions in an area with high incidence of tuberculosis[J]. Chest, 1996, 109(1):158-162. DOI URL
[2]	VERMA A, ABISHEGANADEN J, LIGHT R W. Identifying malignant pleural effusion by a cancer ratio(serum LDH:pleural fluid ADA ratio)[J]. Lung, 2016, 194(1):147-153. DOI URL
[3]	VERMA A, DAGAONKAR R S, MARSHALL D, et al. Differentiating malignant from tubercular pleural effusion by cancer ratio plus(cancer ratio:pleural lymphocyte count)[J]. Can Respir J, 2016, 2016:7348239.
[4]	LEE S J, KIM H S, LEE S H, et al. Factors influencing pleural adenosine deaminase level in patients with tuberculous pleurisy[J]. Am J Med Sci, 2014, 348(5):362-365. DOI URL
[5]	陆晓芳, 宋珊珊, 孙婷婷, 等. Sysmex XN-9000型血细胞分析仪与牛鲍手工法在体液标本检测中的应用效果及对肿瘤细胞筛查敏感度分析[J]. 中国医药, 2019, 14(2):294-296.
[6]	董静肖, 崔世伟, 高远, 等. 高荧光强度细胞对浆膜腔积液诊断的价值[J]. 北京医学, 2018, 40(9):837-840.
[7]	罗丽贞, 刘春林, 吴清念, 等. Sysmex XE-5000血液分析仪体液模式筛查肿瘤细胞价值的评价[J]. 检验医学, 2014, 29(2):169-171.
[8]	WU W, ZHAO C, SHEN T, et al. The diagnostic ability of high-fluorescent cells combined with carcinoembryonic antigen for malignant pleural effusion[J]. Int J Lab Hematol, 2019, 41(4):509-512.
[9]	KORCZYŃSKI P, MIERZEJEWSKI M, KRENKE R, et al. Cancer ratio and other new parameters for differentiation between malignant and nonmalignant pleural effusions[J]. Pol Arch Intern Med, 2018, 128(6):354-361.

组别	例数	HF#/（个/μL）	HF%/%	血清LDH/胸腔积液ADA比值
良性组	156	18（5~74）	1.0（0.3~4.5）	11.29（3.93~19.57）
恶性组	120	127（46~288）^*	13.1（4.7~25.6）^*	20.24（14.17~32.18）^*

组别	例数	HF#/（个/μL）	HF%/%	血清LDH/胸腔积液ADA比值
良性组	156	18（5~74）	1.0（0.3~4.5）	11.29（3.93~19.57）
恶性组	120	127（46~288）^*	13.1（4.7~25.6）^*	20.24（14.17~32.18）^*

年龄	良性胸腔积液患者	恶性胸腔积液患者
<60岁	5.43（3.31~16.48）	20.59（15.94~39.80）^*
≥60 岁	14.23（8.40~20.90）	19.88（13.84~31.71）^*

年龄	良性胸腔积液患者	恶性胸腔积液患者
<60岁	5.43（3.31~16.48）	20.59（15.94~39.80）^*
≥60 岁	14.23（8.40~20.90）	19.88（13.84~31.71）^*

[1]	LI Li, SHI Huaying, Zaxiyangzong , Dawazhuoma , CHEN Yanmei, YANG Chunjiao, WEN Honglin. Application of indirect method in establishing reference range of adult blood lipids in Lhasa [J]. Laboratory Medicine, 2025, 40(11): 1064-1069.
[2]	SHEN Zhiying, CHEN Ming, DONG Yueying. Correlation between serum Hcy，S100B levels and cerebral metabolite indicators and cognitive impairment in elderly AIS patients [J]. Laboratory Medicine, 2025, 40(11): 1097-1101.
[3]	CHEN Wenli, JIN Cheng, ZHOU Lulu, XU Weiyi. Role of MicroR in guiding platelet count re-examination [J]. Laboratory Medicine, 2025, 40(9): 897-900.
[4]	WANG Qiuju, XIAO Huijian, WU Shuang, ZHAO Wanting, DAI Xubo, ZHUANG Yuepeng. Role of peripheral blood lymphocyte morphological classification in curative effect judgment of critical influenza [J]. Laboratory Medicine, 2025, 40(9): 901-906.
[5]	ZHANG Hui, YUAN Jingwen, ZHANG Chi. Adult reference ranges for platelet count and platelet-related parameters using fluorescence method in Wuhan [J]. Laboratory Medicine, 2025, 40(9): 892-896.
[6]	SHI Shaoxin, CHEN Xueting, XU Xiaofeng, LU Renquan, GUO Lin, ZHUANG Yihui. Role of coagulation function in bacterial bloodstream infection among malignant tumor patients [J]. Laboratory Medicine, 2025, 40(8): 804-809.
[7]	JIANG Fengying, JIANG Yun, MI Rui, QIAN Ximing, WANG Qiubo. Changes of platelet and coagulation function indicators in elderly patients with diabetic foot ulcers [J]. Laboratory Medicine, 2025, 40(7): 708-712.
[8]	YAO Lifeng, ZHANG Ling. Research progress on clinical significance of monocyte distribution width in infection and inflammatory diseases [J]. Laboratory Medicine, 2025, 40(5): 503-507.
[9]	DAI Jingwen, YANG Shuo, WANG Chong, SUN Lin, GU Meixiu, XIAN Jingrong, PAN Baishen, WANG Beili, ZHANG Chunyan, GUO Wei. Role of preoperative mean corpuscular hemoglobin concentration for predicting postoperative recurrence in intrahepatic cholangiocarcinoma patients [J]. Laboratory Medicine, 2025, 40(4): 344-349.
[10]	ZHANG Haoyang, LU Lin, ZONG Ming, HE Long, DING Yuanyuan, FAN Lieying. Diagnostic and predictive value of white blood cell population data in patients with sepsis [J]. Laboratory Medicine, 2025, 40(3): 271-277.
[11]	ZHOU Jiakuan, GUO Ping, CAI Qi, YANG Mingkang, HUANG Zhixi, XUE Yilun, HUA Renxiang, LIN Han, LI Jiaming, WANG Jianbiao. Molecular epidemiological analysis of patients with increased stomatocytes and giant platelets in peripheral blood [J]. Laboratory Medicine, 2025, 40(2): 171-177.
[12]	WANG Chengyun, GU Ping, PAN Qiuhui, WANG Jing. Changes and clinical value of blood coagulation indexes in children with infection [J]. Laboratory Medicine, 2025, 40(2): 178-181.
[13]	. [J]. Laboratory Medicine, 2025, 40(2): 197-200.
[14]	ZHANG Lan, ZHU Jianfeng, PAN Baishen, CHEN Pu, WANG Beili, GUO Wei. Prognostic value of circulating plasma cells determined by morphology in newly diagnosed multiple myeloma [J]. Laboratory Medicine, 2025, 40(1): 15-19.
[15]	CUI Weiqi, OU Xinyang, ZHAO Chunhe, XIA Wei, QU Linlin. Progress of thrombin-activatable fibrinolysis inhibitor determination in clinical application [J]. Laboratory Medicine, 2024, 39(10): 1021-1026.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 9

Related Articles 15

Recommended Articles

Metrics